ADMA vs TFX · P/E 22, rev $238.9M vs P/E 2083, rev $1.12B
ADMA Biologics Inc (ADMA) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the ADMA and TFX stock pages for the full models.
Not investment advice.